Cross Country Healthcare (CCRN) Tops Q1 EPS by 9c; misses on guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q1 EPS of $0.84, $0.09 better than the analyst estimate of $0.75. Revenue for the quarter came in at $622.71 million versus the consensus estimate of $595.03 million.

GUIDANCE:

Cross Country Healthcare sees Q2 2023 EPS of $0.55-$0.65, versus the consensus of $0.75. Cross Country Healthcare sees Q2 2023 revenue of $530-540 million, versus the consensus of $553.9 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
• Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance